David Klein

David Klein

Auto-generated profile, based on publicly available information

David Klein

Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94304, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
VGVeronica Gonzalez-Pena
Veronica Gonzalez-Pena
SNSivaraman Natarajan
Sivaraman Natarajan
YXYuntao Xia
Yuntao Xia
DKDavid Klein
David Klein
RCRobert Carter
Robert Carter
CGCharles Gawad
Charles Gawad
Significance: Primary template-directed amplification (PTA) is a major improvement in whole genome amplification, which is required to study intratissue cellular evolution. As presented in the manuscript, PTA produces significantly improved and reproducible genome sequencing coverage and variant detection from a single genome of a single cell. Applications of measuring genetic diversity from single cells with PTA presented in the manuscript include examining the acquisition of genetic changes during normal development and aging, measuring the consequences of specific perturbations such as genome editing, and characterizing the evolution of clonal populations during cancer formation.

22 April 2022 in Science Advances
Verified
Journal Article
Open access
VBValentin Barsan
Valentin Barsan
YXYuntao Xia
Yuntao Xia
DKDavid Klein
David Klein
VGVeronica Gonzalez-Pena
Veronica Gonzalez-Pena
SYSarah Youssef
Sarah Youssef
CGCharles Gawad
Charles Gawad
Treatment of acute lymphoblastic leukemia (ALL) necessitates continuous risk assessment of leukemic disease burden and infections that arise in the setting of immunosuppression. This study was performed to assess the feasibility of a hybrid capture next-generation sequencing panel to longitudinally measure molecular leukemic disease clearance and microbial species abundance in 20 pediatric patients with ALL throughout induction chemotherapy. This proof of concept helps establish a technical and conceptual framework that we anticipate will be expanded and applied to additional patients with leukemia, as well as extended to additional cancer types. Molecular monitoring can help accelerate the attainment of insights into the temporal biology of host-microbe-leukemia interactions, including how those changes correlate with and alter anticancer therapy efficacy. We also anticipate that fewer invasive bone marrow examinations will be required, as these methods improve with standardization and are validated for clinical use.

9 May 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
PPPhilip L. Perez
Philip L. Perez
KCKristine L. Cueva
Kristine L. Cueva
CRClark A. Rosen
Clark A. Rosen
VYVyVy N. Young
VyVy N. Young
MNMolly L. Naunheim
Molly L. Naunheim
SCSteven W. Cheung
Steven W. Cheung